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Phytolacca dioicaWe investigated the antimicrobial activity of PD-L4, a type 1 RIP from Phytolacca dioica. We found
that this protein is active on different bacterial strains both in a native and denatured/alkylated
form and that this biological activity is related to a cryptic peptide, named PDL440–65, identified
by chemical fragmentation. This peptide showed the same antimicrobial activity of full-length
protein and possessed, similarly to several antimicrobial peptides, an immunomodulatory effect
on human cells. It assumes an alpha-helical conformation when interact with mimic membrane
agents as TFE and likely bacterial membranes are a target of this peptide. To date PDL440–65 is the
first antimicrobial peptide identified in a type 1 RIP.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Ribosome-inactivating proteins (RIPs) are N-b-glycosylase (EC:
3.2.2.22) which remove a single adenine residue (A4324 in rat liver
ribosomal ribonucleic acid [rRNA] [1]) from the sugar-phosphate
backbone of 28S rRNA. These enzymes, identified mainly in plants
but also in fungi and bacteria [2,3], are divided into two groups [4]:type 1 RIPs, consisting of a single enzymatically active chain and
type 2 RIPs, made of two chains, one catalytically active (similar
to type 1 RIPs and named A chain) and the other containing a lectin
domain (B chain). Type 2 RIPs are generally extremely toxic to
many cell types because the lectin B chain facilitates their entry
[5], with exceptions like, for instance, those present in Sambucus
[6]; on the contrary type 1 RIPs, devoid of a lectin binding chain,
are internalized much less efficiently by cells and consequently
have relatively low toxicity [7].
The enzymology of RIPs has been well characterized, whereas
their biological and physiological functions in plants have not yet
fully clarified. For this reason, biological role of RIPs in plants
remains open to argumentations [8]. It is proposed that they are
involved in plant defence in abiotic and biotic stress [8]. RIPs are
often found in large amounts in different plant tissues such as
leaves (e.g. saporin S-6 from Saponaria officinalis L. [9,10]) and
seeds (e.g. ricin from Ricinus communis L. [11]) therefore some
authors consider RIPs also as storage proteins [12]. Whatever
their physiological role, the interest for these enzymes is due to
their potential use (i) for the development of immunotoxins for
tumor therapy [13], (ii) for their use as natural phyto-pesticides
[14,15], and (iii) for the production of transgenic plants endowed
with specific parasite resistance [16,17]. It was found that many
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cleic acid (DNA) or from other polynucleotides [18]; recent
reports revealed that some RIPs possess RNase or DNase activi-
ties, superoxide dismutase (SOD) or phospholipase properties
[8,19].
In the last decade, many authors reported that antimicrobial
activity of several cationic proteins is due to their structural
characteristics and not necessarily to their functional/enzymatic
properties [20]. More particularly, antimicrobial activity depends
essentially on specific stretches of residues or cryptic peptides
detectable in the primary structure of proteins. Among these,
cationic antimicrobial peptides (commonly named CAMPs) are
able to interact with the bacterial membrane through electrostatic
interactions, hence they can cause direct cell death or significantly
alter cell survival by damaging membrane or by binding to specific
intracellular target crossing membranes. Some of these cationic
peptides, identified in RNases [21], lysozymes [22], lactoferrin
[23], thrombin [24], have been thoroughly investigated.
In this framework lies type 1 RIPs that are cationic and so able
to bind strongly negative substrates, as polyanions (e.g. RNA, DNA,
etc.) [1,7,8]. Because in general cationic proteins possess intrinsic
antimicrobial properties (see above), we thought to verify if also
a type 1 RIP showed antimicrobial activity on different bacterial
strains and to identify possibly structural determinants that could
confer this property. In order to test this proof of concept we
choose PD-L4, a type 1 RIP isolated from Phytolacca dioica L. sum-
mer leaves, which is enzymatically and structurally well character-
ized [25–27].
2. Materials and methods
2.1. Materials and general procedures
All chemicals utilized in this work were of analytical grade and,
except where indicated, were purchased from Sigma–Aldrich
(Milan, Italy).
Bacterial cultures, plasmid purifications and transformations
were performed according to Sambrook [28]. Protein sequence
determinations were performed as previously reported [29], using
a Procise sequencer, Model 491C (Applied Biosystems, Foster City,
CA).
Bacterial strains used for antimicrobial activity assays were:
Pseudomonas aeruginosa PAOI, Staphylococcus aureus ATCC 6538P,
Escherichia coli DH5a and Agrobacterium tumefaciens AGL0.
2.2. Peptide synthesis
The peptide PDL440–65 was synthesized by InBios (Naples, Italy)
using solid-phase 9-fluorenylmethoxy carbonyl (Fmoc) chem-
istry and purified to a purity >95% using reverse-phase high-
performance liquid chromatography (HPLC). Peptide mass was
confirmed by mass spectrometry.
2.3. Protein purification and the its chemical (with CNBr)
fragmentation
Expression, refolding and purification of recombinant rPD-L4 in
E. coli expression system were performed according to Del Vecchio
Blanco et al. [30]. Each step of the expression and purification pro-
cedure was monitored by SDS–PAGE analyses. The eluted protein
from the cation exchange chromatography on SOURCE 15S
4.6/100 PE column (1.7 mL) using Akta purifier system (GE Health-
care, Milan, Italy) was collected, dialyzed, and kept frozen until
use. Chemical fragmentation by CNBr method and corresponding
results are reported in Supplemental Material section.2.4. Anti-microbial activity assay
A single colony of P. aeruginosa, E. coli, S. aureus or A. tumefaciens
was suspended in 5 mL of LB (Luria–Bertani medium; Difco,
Detroit, MI) and incubated overnight at 37 C. When the culture
reached an OD600 of 1 unit, it was diluted 1:100 in 20 mM Na/P,
pH 7.0. Samples were prepared by adding 40 lL of bacterial cells
and the peptide, native protein or denatured protein at different
concentrations and adjuster to 1 mL final volume was reached
with 20 mM Na/P at pH 7.0. Negative controls were represented
by cells incubated without any compound or with BSA, and
assayed at the same concentration of tested molecules; cells
incubated with 0.05 mg/mL ampicillin (for E. coli and S. aureus),
0.01 mg/mL colistin (for P. aeruginosa) or 0.05 mg/mL carbenicillin
(for A. tumefaciens) were used as positive control. All samples were
first incubated at 37 C for 4 h, and then corresponding dilutions
(1:100 and 1:1000) were plated on solid LB medium plates and
incubated overnight at 37 C. The following day survived cells were
estimated by colonies counting on each placed and compared with
the controls. All compounds were tested in triplicate experiments,
standard deviations were always <5% for each experiment.
2.5. DAPI/PI dual staining and fluorescence microscopy image
acquisition
A working solution (5 lg/mL) of 40,6-diamidino-2-phenylindole
dihydrochloride (DAPI; Sigma Aldrich) was prepared by dissolving
the content of a 25 mg package in sterile Milli-Q water and stored
at 20 C until used. For the dual staining, 10 lL of E. coli culture
were mixed with 5 lL of DAPI solution (1 lg/mL DAPI final concen-
tration) and 10 lL of 120 lM propidium iodide (Sigma Aldrich)
[31] and incubated in the dark for 30 min at room temperature
[32]. Samples were observed using an Olympus BX51 fluorescence
microscope using a DAPI (Sigma, Aldrich) filter. Standard acquisi-
tion time was 1000 ms for DAPI/PI dual staining and the Images
were captured using an Olympus DP70 digital camera and
processed [33].
2.6. SDS–PAGE and western immunoblot analysis
CaCo-2 or HaCat cells were harvested in lysis buffer [50 mM
TrisCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% NP-40, 1 mM
phenylmethyl-sulfonyl fluoride, 0.5% sodium deoxycholate, and
protease inhibitors (SIGMAFASTTM Tablets, Sigma–Aldrich)]; corre-
sponding total protein extracts were prepared as previously
described [34]. Briefly, cell lysates were incubated on ice for
40 min and then centrifuged at 15,000g for 15 min to remove cell
debris. Protein concentration of resulting supernatants was then
determined by using Bio-Rad protein assay kit (Bio-Rad, Rome
Italy). Finally, after the addition of 2 Laemmli buffer (Sigma
Aldrich), samples were boiled at 100 C for 5 min and resolved by
SDS–polyacrylamide gel electrophoresis (10% or 12%) and subse-
quently proteins were transferred to polyvinylidenedifluoride
(PVDF) membranes (Millipore Milan, Italy) as described elsewhere
[34]. Membranes were blocked in 5% w/v milk buffer (5% w/v non-
fat dried milk in 50 mM TrisCl pH 8.0 containing 200 mMNaCl and
0.2% Tween 20). Then membranes were incubated with primary
antibody diluted in 5% w/v milk or bovine serum albumin in TrisCl
pH 8.0 200 mM NaCl, 0.2% Tween-20, pH 8.0 for 2 h at room tem-
perature or overnight at 4 C. Primary antibodies were anti-rabbit
pErks 42/44 (Cell Signaling, EuroClone, Milan, Italy), anti-goat
b-actin (Santa-Cruz Biotechnology DBA Milan, Italy). Data were
visualized by enhanced chemi-luminescence method (ECL,
GE-Healthcare Milan, Italy) using HRP-conjugated secondary
antibody (Santa-Cruz Biotechnology DBA) incubated 1 h at room
Fig. 1. Antibacterial activity on E. coli (black bars), P. aeruginosa (dark gray bars), S.
aureus (white bars) and A. tumefaciens (light gray bars) of recombinant PD-L4 or its
denatured and alkylated form. Positive control for each strain was performed using
the appropriate antibiotic which concentrations are indicated in methods (Sec-
tion 2.4). Standard deviations were always <5% for each experiment.
Fig. 2. Antibacterial activity on E. coli (black bars), P. aeruginosa (dark gray bars), S.
aureus (white bars) and A. tumefaciens (light gray bars) of PDL440–65 peptide
compared to recombinant PD-L4 and its denatured or alkylated form. Standard
deviations were always <5% for each experiment.
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DocTM XRS system (Bio-Rad).
3. Results and discussion
3.1. Antimicrobial activity of native and denatured PD-L4 on different
bacteria
PD-L4 was produced as recombinant protein (rPD-L4), as
described in Supplementary Materials (see Fig. S1A). Its antibacte-
rial activity was analyzed on E. coli, P. aeruginosa, S. aureus and on
the plant pathogen A. tumefaciens (Fig. 1). As for many cationic
enzymes, their antimicrobial activity is not necessarily related to
their intrinsic catalytic efficacy, we decided to test also the antimi-
crobial activity of rPD-L4 previously subjected to denaturation fol-
lowed by S-pyridylethylation. As shown in Fig. 1, both rPD-L4 and
its chemically modified form, when assayed at 3 lM, showed a sim-
ilar antimicrobial activity. This result demonstrates that rPD-L4
cytotoxic propensity is likely due to its intrinsic aminoacidic com-
position. A similar antimicrobial trend for denatured rPD-L4 has
been obtained also modifying it with different alkylating agents,
such as bromopropilamine and iodoacetic acid, (data not shown).
3.2. Analysis of antimicrobial activity of PD-L4 peptides obtained by
chemical fragmentation
Since results above described were obtained on full-length
native or denatured protein, in order to verify if bactericidal action
of rPD-L4 was due to a specific cluster of residues, we decided to
subject rPD-L4 to a chemical fragmentation by CNBr (see Supple-
mental Material). As shown in Fig. S1B, rPD-L4 sequence contains
5 methioninyl residues, so that CNBr fragmentation determines a
theoretical pattern of fragmentation, consisting of six peptides.
CNBr reaction mixture (see methods) has been subjected to
reduction by b-mercaptoethanol and S-pyridylethylation followed
by RP-HPLC (Fig. S2A). Fragments, corresponding to main peaks,
were so identified by Edman degradation and MALDI-TOF MS
(Fig. S2B) and then assayed.
Antimicrobial assays on P. aeruginosa, revealed that only peptide
5, corresponding to residues 40–65, showed a significant bacterici-
dal action (data not shown). Based on this indication, we tested this
peptide, named PDL440–65, on E. coli, P. aeruginosa, S. aureus and on
A. tumefaciens and compared it to the activity of native or dena-
tured/alkylated rPD-L4 (Fig. 2). In all considered cases, antimicro-
bial action of PDL440–65, was comparable to that of both protein
forms and was dose dependent, as shown in Supplemental Fig. S3.
These data strongly support the hypothesis that cytotoxic action
of rPD-L4 is due to structural properties of peptide PDL440–65.
Since CAMPs usually directly damage target membranes, we
performed a fluorescence microscopy experiment to verify the
effect of PDL440–65 on bacterial membranes. To test this action,
we used E. coli cells, DAPI as fluorescent stain for DNA and propid-
ium iodide, the latter detectable only in cells with damaged mem-
branes and therefore it is an useful indicator of cell death. As
shown in Fig. 3 (panel 1), results obtained point out that a signifi-
cant amount of cells, after treatment with PDL440–65, developed a
red fluorescence light as a consequence of a possible impairment
of membrane integrity. Same trend has been observed on E. coli
cells treated with rPD-L4 (Fig. 3, panel 2). As expected, fluorescence
developed by untreated cells was blue because intact membranes
avoid the entry of propidium iodide [35].
3.3. Conformational studies of PDL440–65 peptide by circular dichroism
Since residues 40–65 in PD-L4 (PDB code: 2Z4U) are structured
as b-sheet fold, we performed circular dichroism experiments tostudy conformational changes of PDL440–65 in buffer solution and
in presence of different mimic membrane agents. Far-UV CD
spectra indicate that PDL440–65 peptide is unstructured in phos-
phate buffer but adopts a a-helical structure already in 30% TFE
and in the presence of 20 mM SDS (Fig. 4). This behavior indicates
that PDL440–65 peptide is prone to assume a specific conformation
when interacting with membrane-mimicking agents like TFE
(trifluoroethanol) or SDS. Alpha helical content of the peptide
was estimated [36] and reported in Fig. 4. It is worth noting that
helix content did not exhibit a significant change at concentrations
of TFE higher than 50%, thus suggesting a high propensity to
acquire an ordered structure. In fact, it has been already shown
that peptides with high helical-propensity reach their maximum
helical content at concentrations of TFE between 30% and 50%
[37]. Besides, it should be noted that PDL440–65 assumes a specific
fold in presence of TFE or SDS, but this conformation is different
with respect to that adopted by residues 40–65 in rPD-L4. This
trend is already described for some peptides that are able to switch
between different secondary structures (generally from a b-sheet
to an a-helical structure [38]) and are known as chameleon
peptides [39].
To further characterize the structural properties of PDL440–65
peptide, we analyzed also its interaction with LPS (lipopolysaccha-
ride), the main constituent of the outer membrane of Gram nega-
tive bacteria. When PDL440–65 peptide was analyzed in presence
Fig. 3. Fluorescence microscopy by DAPI/PI dual staining on E. coli cells treated with
rPD-L4 (Panel 1B) or treated with PDL440–65 peptide (Panel 2B). Panels 1A and 2A
refer to untreated cells. Corresponding 1–2 C and 1–2 D refer to optical analysis.
Fig. 5. Effects of PDL440–65 on CaCo-2 and HaCat cells. Cells were grown for 24, 48
and 72 h in presence of 3 or 30 lM of peptide. Cell survival values (means of
triplicates) are expressed as percent of the corresponding values obtained in control
cultures grown in the absence of peptide. Standard deviations were always <5% for
each experiment.
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dichroic spectra indicated that the peptide was random coiled
(data not shown) and so likely not able to bind LPS.Fig. 4. CD spectra of PDL440–65 peptide in phosphate buffer (black line), in the
presence of different concentrations of TFE or in presence of 20 mM SDS. In table are
reported secondary structure content (%) obtained by deconvoluted CD data.3.4. Cytotoxicity assays and inflammatory properties of PDL440–65
peptide on human cells
As already underlined above, the promising interest in the use
of CAMPs as alternative antibiotics stems from their selective
action on bacterial cells with respect to eukaryotic cells. We thus
studied the cytotoxic effect of PDL440–65 peptide towards two dif-
ferent human cell lines, HaCat and CaCo-2 cells. Addition of
increasing concentrations (3 and 30 lM) of PDL440–65 peptide to
HaCat or CaCo-2 cells, at three different times of incubation (24,
48 or 72 h), did not result in any significant effect on viability of
cells as judged by measuring mitochondrial functionality (Fig. 5).
It is known that several CAMPs have the ability to block the pro-
duction of cytokines produced in response to LPS by either directly
up-regulating inhibitory pathways in cells [40] or interfering with
the ability of LPS to bind LPS-binding proteins. In order to investi-
gate the hypothesis that PDL440–65 peptide might elicit anti-
inflammatory effects and thus immunomodulatory activities on
human cells, although it is not able to interact with LPS (see CD
section), we analyzed by western blotting its effects on LPS-
treated CaCo-2 cells. As shown in Fig. 6, in CaCo-2 cells subjectedFig. 6. Effect of PDL440–65 peptide on ERK phosphorylation level in CaCo-2 cells by
western blotting. Protein extracts from CaCo-2 cells, treated as described in
Section 2.6, were analyzed as follows: lane C, protein extract from untreated cells;
lane 1–4, protein extracts from CaCo-2 cells under different conditions. Lane 1, LPS
treatment (1 h); lane 2, peptide alone (1 h); lane 3, PDL440–65 and LPS simultane-
ously administrated (1 h); lane 4, pre-treatment (1 h) with LPS and subsequently
incubation (1 h) with PDL440–65.
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tyrosine phosphorylation level (lane 1), whereas this cytokine
decreased when PDL440–65 peptide was administrated simultane-
ously to LPS (lane 3). A similar trend has been observed also when
CaCo-2 cells were pre-treated with LPS and subsequently
incubated with PDL440–65 (lane 4). It should be also noted that
incubation of CaCo-2 cells with PDL440–65 alone (lane 2) does not
alter significantly ERK tyrosine phosphorylation level. This set of
evidences indicates that PDL440–65 is able to trigger an
anti-inflammatory response in LPS treated CaCo-2 cells albeit CD
analysis showed no direct binding to LPS.
3.5. Comparative analysis in family
In order to verify if antimicrobial peptides similar to PDL440–65
are present in other type 1 RIPs from Phytolaccaceae [41] a multiple
alignment with PD-L4 was carried out (Fig. S4). A region
homologous to PDL440–65 (position 41–71, numbering accordingFig. 7. (A) Extract of multi alignment of type 1 RIPs from Phytolaccaceae. Asterisks and hig
on the right side. Identical residues (⁄), conserved substitutions (:) and semi-conserved s
Supplement Materials. (B) Antimicrobial activity scores for two different bacterial strai
obtained by the bioinformatics tool described in the text.to the consensus sequence) was detected and the corresponding
identity and similarity values are reported in Fig. S5.
This region, highlighted in Fig. 7A, shows the presence of six
conserved residues (K9, Y10, L12, L15, T28 and L29). Almost all
the examined peptides are cationic (net positive charges from +1
to +3) with the exception of peptides from dioicin 2 and PAP-II
which show null net charge.
Given the apparent heterogeneity of the sequences, we decided
to analyze them through a recently developed bioinformatics
approach [42] that allows to assign an ‘‘antimicrobial potency
score” to any peptide of known sequence. This approach is based
on the finding that antimicrobial potency [defined as the Log (1/
MIC)] increases linearly with the product CmHnL where C is the
net charge, H is a measure of the hydrophobicity of the hydropho-
bic residues and L is the length of the peptide. Exponents m and n
are strain dependent variables that determine the relative weight
of charge and hydrophobicity on the score and potency of the
peptide. These two values are strain specific and can only behlighting in gray refer to conserved residues. Net charge (D) of peptides is indicated
ubstitutions (.) are reported. For the accession number of proteins see paragraph 1.5
ns (P. aeruginosa and S. aureus) of peptides reported in panel A. Scores have been
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using exponents determined for a Gram negative strain
(P. aeruginosa) and a gram positive strain (S. aureus). As shown in
Fig. 7B also the bioinformatics approach shows a very heteroge-
neous picture with scores that range from 0 (for the two peptides
with net charge = 0) to 6.5–7, a score that corresponds to MIC val-
ues in the range 100–50 lM [42]. Very interestingly, the highest
scores, indicated with asterisks, were found in the case of three
proteins, PD-L2, PAP-S1aci and PAP-S. This analysis suggests the
existence of a new putative family of antimicrobial peptides in
Phytolaccaceae and that PDL440–65 is the first member of this class
to be experimentally characterized.
4. Conclusions
Cationic antimicrobial peptides (CAMPs) are ancestral elements
of the innate immune system and are present in all multicellular
organisms. The majority of CAMPs, in spite of their different origin,
share common structural parameters, as small size, cationicity, and
amphipathicity. A wide variety of cationic proteins includes, inside
their primary structure, CAMPs that can be defined ‘‘cryptic”.
PD-L4 is a type 1 RIP from P. dioicawell characterized from a struc-
tural, functional and enzymatic point of view. This paper reports
for the first time the characterization of its antimicrobial
properties. Our data indicate that a cryptic peptide, encompassing
residues 40–65 of full-length protein, showed a significant antimi-
crobial activity on different bacterial strains and an intriguing
immunomodulatory effect on human cells. An in silico analysis
allowed to identify homologous cryptic peptides in other type 1
RIPs from Phytolaccaceae. As some of these cryptic CAMPs belong
to seed proteins, it could be speculated that these bioactive mole-
cules play a key role during seedling development, a process
strongly susceptible to attack by pathogens. This possibility is
supported by some studies describing the degradation of RIPs
during seedling development [43,44]. Fragments released by the
degradation process could participate to defense by exerting direct
antimicrobial effects as shown for PDL440–65.
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